Little research has been aimed at identifying the vasoconstrictor agent and dose of choice in this group of patients; however, publications concerning severe preeclamptics have used a 3 to 6 mg dose of ephedrine with suitable outcomes.
Falta investigación para identificar el vasopresor y la dosis de elección en este grupo de pacientes.